Transgenomic
Products for purification and analysis of nucleic acids used in the life sciences industry for research.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| N/A | $3.0m | Post IPO Debt | |
$7.0m | Post IPO Equity | ||
| N/A | $750k | Post IPO Debt | |
| N/A | $3.0m | Post IPO Equity | |
| N/A | $1.5m | Grant | |
| N/A | $2.2m | Post IPO Equity | |
| N/A | $1.2m | Post IPO Equity | |
| Total Funding | €1.4m | ||
Related Content
Recent News about Transgenomic
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.